312 related articles for article (PubMed ID: 11595431)
1. Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes.
Kunikata T; Araki H; Takeeda M; Kato S; Takeuchi K
J Physiol Paris; 2001; 95(1-6):157-63. PubMed ID: 11595431
[TBL] [Abstract][Full Text] [Related]
2. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors.
Kunikata T; Tanaka A; Miyazawa T; Kato S; Takeuchi K
Dig Dis Sci; 2002 Apr; 47(4):894-904. PubMed ID: 11991626
[TBL] [Abstract][Full Text] [Related]
3. The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach.
Araki H; Ukawa H; Sugawa Y; Yagi K; Suzuki K; Takeuchi K
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():116-24. PubMed ID: 10807413
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin EP receptors and their roles in mucosal protection and ulcer healing in the gastrointestinal tract.
Takeuchi K
Adv Clin Chem; 2010; 51():121-44. PubMed ID: 20857620
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E inhibits indomethacin-induced gastric lesions through EP-1 receptors.
Suzuki K; Araki H; Mizoguchi H; Furukawa O; Takeuchi K
Digestion; 2001; 63(2):92-101. PubMed ID: 11244247
[TBL] [Abstract][Full Text] [Related]
7. Facilitation by endogenous prostaglandins of capsaicin-induced gastric protection in rodents through EP2 and IP receptors.
Takeuchi K; Kato S; Takeeda M; Ogawa Y; Nakashima M; Matsumoto M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1055-62. PubMed ID: 12604682
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats through EP1 receptors.
Hase S; Yokota A; Nakagiri A; Takeuchi K
Life Sci; 2003 Dec; 74(5):629-41. PubMed ID: 14623033
[TBL] [Abstract][Full Text] [Related]
9. Involvement of cyclooxygenase-1, prostaglandin E2 and EP1 receptors in acid-induced HCO3- secretion in stomach.
Takeuchi K; Aihara E; Sasaki Y; Nomura Y; Ise F
J Physiol Pharmacol; 2006 Dec; 57(4):661-76. PubMed ID: 17229989
[TBL] [Abstract][Full Text] [Related]
10. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice.
Takeuchi K; Araki H; Umeda M; Komoike Y; Suzuki K
J Pharmacol Exp Ther; 2001 Jun; 297(3):1160-5. PubMed ID: 11356942
[TBL] [Abstract][Full Text] [Related]
11. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
[TBL] [Abstract][Full Text] [Related]
12. Involvement of prostaglandin E receptor EP3 subtype and prostacyclin IP receptor in decreased acid response in damaged stomach.
Nishio H; Terashima S; Nakashima M; Aihara E; Takeuchi K
J Physiol Pharmacol; 2007 Sep; 58(3):407-21. PubMed ID: 17928639
[TBL] [Abstract][Full Text] [Related]
13. Biphasic effect of prostaglandin E2 in a rat model of esophagitis mediated by EP1 receptors: relation to pepsin secretion.
Yamato M; Nagahama K; Kotani T; Kato S; Takeuchi K
Digestion; 2005; 72(2-3):109-18. PubMed ID: 16172547
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors.
Hatazawa R; Tanaka A; Tanigami M; Amagase K; Kato S; Ashida Y; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G788-97. PubMed ID: 17673547
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity.
Takeuchi K; Kato S; Amagase K
J Pharmacol Sci; 2010; 114(3):248-61. PubMed ID: 21041985
[TBL] [Abstract][Full Text] [Related]
16. EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells.
Takahashi S; Takeuchi K; Okabe S
Biochem Pharmacol; 1999 Dec; 58(12):1997-2002. PubMed ID: 10591156
[TBL] [Abstract][Full Text] [Related]
17. Importance of cyclooxygenase-1/prostacyclin in modulating gastric mucosal integrity under stress conditions.
Amagase K; Izumi N; Takahira Y; Wada T; Takeuchi K
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():3-10. PubMed ID: 25521725
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin EP receptor subtypes involved in regulating HCO(3)(-) secretion from gastroduodenal mucosa.
Takeuchi K; Koyama M; Hayashi S; Aihara E
Curr Pharm Des; 2010; 16(10):1241-51. PubMed ID: 20166995
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
Walch L; Clavarino E; Morris PL
Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
[TBL] [Abstract][Full Text] [Related]
20. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
